The Milken Institute Global Conference is the Institute’s flagship annual convening, bringing together leaders across health, finance, business, technology, philanthropy, and public policy. The 2026 conference focuses on translating recent disruption and innovation into practical solutions for a more sustainable, equitable, and resilient future.
It is a unique experience in which individuals with the capital and influence to change the world connect with those whose expertise and creativity are reinventing health, finance, business, technology, philanthropy, industry, and society.
The 29th annual Global Conference will convene our diverse and forward-thinking community to tackle these urgent issues and seize opportunities to collectively shape a more sustainable, equitable, and resilient future.
For more information click here.
In 2026, M&A and IPO markets have exhibited diverging dynamics across transaction types, with largescale strategic deals and selective equity issuance shaping the opportunity set for corporates and sponsors alike. Strategic M&A remains robust, while IPO issuance and sponsor exits are increasingly concentrated in higher quality, scaled issuers amid valuation discipline and still discerning financing markets. This panel examines how IPO windows are forming, how companies are preparing for public markets, and how boards are weighing timing, structure, and execution risk across sale, IPO, and dual track options. Panelists also discuss financing conditions, cross border activity, and alternative pathways for capital formation.
